ストックスクリーナーアプリを入手
182.82
1.94%
-3.62
プレマーケット:
183.44
0.62
+0.34%
前日終値:
$186.44
開ける：
$182.78
24時間の取引高:
1.73M
Relative Volume:
1.38
時価総額：
$26.52B
収益：
$5.54B
当期純損益:
$1.52B
株価収益率:
17.62
EPS:
10.3734
ネットキャッシュフロー:
$1.74B
1週間 パフォーマンス:
-12.10%
1か月 パフォーマンス:
-10.83%
6か月 パフォーマンス:
-27.12%
1年 パフォーマンス:
-25.08%
1日の値動き範囲:
$180.26
$184.84
1週間の範囲:
$180.26
$211.56
52週間の値動き範囲:
$180.26
$293.81
Resmed Inc Stock (RMD) Company Profile
Compare RMD vs ISRG, BDX, ALC, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
182.82 | 27.04B | 5.54B | 1.52B | 1.74B | 10.37 |
ISRG
Intuitive Surgical Inc
|
402.30 | 146.01B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.43 | 40.04B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.28 | 32.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.19 | 30.23B | 29.14B | 1.07B | 1.05B | 1.1956 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | 開始されました | JP Morgan | Overweight |
| 2025-12-16 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | 開始されました | Citigroup | Buy |
| 2025-09-02 | アップグレード | CLSA | Hold → Outperform |
| 2025-07-15 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide? - Yahoo Finance
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million - Benzinga
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million - Yahoo Finance
Could Cash Machine ResMed Stock Be Your Next Buy? - Trefis
Transcript : ResMed Inc. Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 04 - marketscreener.com
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Air Voel Strengthens CPAP Repair Support for ResMed PAP Device Users in Canada - Scott Coop
RMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Resmed completes $340M Noctrix takeover - MedTech Dive
Resmed completes Noctrix Health acquisition - Medical Buyer
ResMed Stock Delivers Strong Cash Yield – Upside Ahead? - Trefis
ResMed Completes Acquisition of Noctrix Health - Moomoo
Are CSL and ResMed shares buys at 52-week lows? - The Motley Fool Australia
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio - Koreabizwire
ResMed: Old fears return - intelligentinvestor.com.au
Resmed completes $340M acquisition of Noctrix Health - MassDevice
ResMed Inc. stock falls Friday, underperforms market - MSN
Resmed Closes Acquisition of Noctrix Health - Moomoo
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
Wearable restless legs therapy offers drug-free sleep help for adults - Stock Titan
1 New 5-Star Stock This Week - Morningstar
ResMed: Transferring Coverage of Global Leader in Respiratory Care Devices - Morningstar
ResMed Inc. (RMD) Stock Analysis: Navigating a 42% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Should you continue to hold Resmed stock in your portfolio? - MSN
Why DroneShield, Lendlease, PlaySide, and ResMed shares are tumbling today - The Motley Fool Australia
ResMed Inc. completed the acquisition of Noctrix Health, Inc. - marketscreener.com
ResMed Inc. stock (US7611521078): shares hover near 52-week low after recent slide - AD HOC NEWS
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases 7,020 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Holdings Lifted by Geode Capital Management LLC - MarketBeat
Eurizon Capital SGR S.p.A. Acquires Shares of 216,193 ResMed Inc. $RMD - MarketBeat
AdvisorShares Investments LLC Takes Position in ResMed Inc. $RMD - MarketBeat
RMD Stock Price, Quote & Chart | RESMED INC (NYSE:RMD) - ChartMill
ResMed Inc (RMD) Stock Down 6.3% -- Now Undervalued? GF Score: 9 - GuruFocus
ResMed (RMD) slides as shares hit a 52-week low amid renewed post-earnings scrutiny - Quiver Quantitative
ResMed stock hits 52-week low at $198.60 amid challenging year By Investing.com - Investing.com South Africa
ResMed stock hits 52-week low at $198.60 amid challenging year - Investing.com Nigeria
ResMed Inc. stock (US7611521078): shares ease while investors look to valuation metrics - AD HOC NEWS
Fideuram Asset Management Ireland dac Acquires New Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
These 3 ASX healthcare stocks have been crushed in 2026. They could be set for a comeback - The Motley Fool Australia
Legal & General Group Plc Increases Stock Holdings in ResMed Inc. $RMD - MarketBeat
Employees Retirement System of Texas Boosts Stock Holdings in ResMed Inc. $RMD - MarketBeat
Fisher Asset Management LLC Raises Stake in ResMed Inc. $RMD - MarketBeat
AlphaQuest LLC Sells 8,469 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Acquired by Allstate Corp - MarketBeat
Form 144: RMD (NYSE) affiliate lists 8,000 shares; insider sold 2,000 - Stock Titan
Jefferies Financial Group Inc. Cuts Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Tandem Investment Advisors Inc. Cuts Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock (US7611521078): sleep-apnea specialist in focus after latest earnings update - AD HOC NEWS
ResMed Stock Near 52-Week Low Despite 21% EPS Growth: Here’s What the GLP-1 Data Actually Shows - TIKR.com
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
7.16%
0.78%
大文字化:
|
ボリューム (24 時間):